Immunologic mechanisms and treatment of acute coronary syndromes
نویسندگان
چکیده
منابع مشابه
Acute coronary syndromes - pharmacological treatment
The term acute coronary syndrome (ACS) describes the spectrum of disease from acute myocardial infarction (MI) to unstable angina, as described in the first article of this feature (p285).The primary cause of these diseases is essentially the same — thrombosis of a coronary artery leading to ischaemia and possibly infarction of the myocardium.The degree of ischaemia or infarct size is related t...
متن کاملPrognostic value of C-Reactive Protein in Acute Coronary Syndromes
Introduction: Coronary artery disease (CAD) is among the most common, serious, chronic and life- threatening illnesses in the world. CAD represents a spectrum of conditions, with acute myocardial infarction at one end of it and silent ischemia at the other. There is growing evidence on importance of prognosis of C- reactive protein (CPR) in unstable angina and this protein is a maker of an adve...
متن کاملPharmacological treatment of acute coronary syndromes.
Many trials have examined the efficacy of medications used in acute coronary syndromes. This paper reviews those now recommended in patients with unstable angina and non-ST-segment elevation myocardial infarction. There are currently seven groups of drugs that are used in the management of such patients.
متن کاملMechanisms of acute coronary syndromes and their implications for therapy.
Copyright © 2013 Massachusetts Medical Society. A therosclerotic lesions in humans typically form over the course of years to decades, one of the longest incubation periods among human diseases. Despite the chronicity of atherosclerosis, thrombotic complications — the most dreaded clinical consequences of this disease — occur suddenly, and often without warning. Our familiarity with the disease...
متن کاملAntiplatelet treatment in acute coronary syndromes
Platelets play a major role in the development of acute coronary syndromes (ACS) and thromboembolic complications during and after percutaneous coronary interventions (PCI). Because of the widespread usage of platelet inhibitor agents in the treatment of patients with a broad spectrum of ACS it appears to be important to review the data concerning the usefulness and limitations of these agents....
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chinese Medical Journal
سال: 2006
ISSN: 0366-6999
DOI: 10.1097/00029330-200612020-00014